Paul L Hess
Affiliation: Duke University Medical Center
- Follow-up of patients with new cardiovascular implantable electronic devices: Is adherence to the experts' recommendations associated with improved outcomes?Paul L Hess
Duke Clinical Research Institute, Durham, North Carolina Duke University Medical Center, Durham, North Carolina Electronic address
Heart Rhythm 10:1127-33. 2013..A 2008 expert consensus statement recommended an in-person follow-up visit between 2 and 12 weeks after the placement of a new cardiovascular implantable electronic device (CIED)...
- Age differences in the use of implantable cardioverter-defibrillators among older patients hospitalized with heart failurePaul L Hess
Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC 27715, USA
J Cardiovasc Electrophysiol 24:664-71. 2013..Practice guidelines recommend the use of ICDs in patients with heart failure (HF) and a left ventricular ejection fraction (LVEF) of ≤ 35% in the absence of contraindications...
- Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: does time to implant matter? A meta-analysis using patient-level data from 4 clinical trialsPaul L Hess
Duke Clinical Research Institute, Durham, North Carolina 27715, USA
Heart Rhythm 10:828-35. 2013..Whether there is an optimal time to place an implantable cardioverter-defibrillator (ICD) more than 40 days after myocardial infarction (MI) in guideline-eligible patients is unknown...
- Use of evidence-based cardiac prevention therapy among outpatients with atrial fibrillationPaul L Hess
Duke Clinical Research Institute, Durham, NC 27715, USA
Am J Med 126:625-32.e1. 2013..Patients with atrial fibrillation often have cardiovascular risk factors or known comorbid disease, yet the use of evidence-based primary and secondary prevention cardiac therapy among atrial fibrillation outpatients is unknown...
- Is cardiac resynchronization therapy an antiarrhythmic therapy for atrial fibrillation? A systematic review and meta-analysisPaul L Hess
Duke Clinical Research Institute, Duke University School of Medicine, PO Box 17969, Durham, NC 27715, USA
Curr Cardiol Rep 15:330. 2013..107 (95 % confidence interval 0.069-0.163). Prospective studies, particularly among patients not meeting traditional CRT criteria, are needed...
- Follow-up of patients with new cardiovascular implantable electronic devices: are experts' recommendations implemented in routine clinical practice?Sana M Al-Khatib
Duke Clinical Research Institute, Department of Medicine, Duke University School of Medicine, Durham, NC 27715, USA
Circ Arrhythm Electrophysiol 6:108-16. 2013..A 2008 expert consensus statement outlined the minimum frequency of follow-up of patients with cardiovascular implantable electronic devices (CIEDs)...
- Outcomes associated with warfarin use in older patients with heart failure and atrial fibrillation and a cardiovascular implantable electronic device: findings from the ADHERE registry linked to Medicare claimsPaul L Hess
Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA
Clin Cardiol 35:649-57. 2012..Warfarin use and associated outcomes in patients with heart failure and atrial fibrillation and a cardiovascular implantable electronic device have not been described previously...